San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma
Accreditation: 5.25 Nursing Contact Hours | 5.25 ABIM MOC II | 5.25 AMA PRA Category 1 Credit™ | 5.25 ACPE Pharmacy
Venue: Sheraton San Diego Resort, San Diego, CA, United States
Official conference page for San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma. https://binaytara.org/projects/conferences/san-diego-hematologic-malignancies-symposium
About San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Saturday, September 19th, 2026
All timings are in Pacific Time (PST, GMT-08:00) time.
Session Chair: Vinod Pullarkat, MD
08:05 AM - 08:20 AM
Evolving Strategies in Acute Leukemias – Vinod Pullarkat, MD
08:20 AM - 08:25 AM
Evolving Strategies in Acute Leukemias (Q&A)
08:25 AM - 08:35 AM
Case 1: Newly diagnosed FLT3+ AML - To Transplant or Not – Tiffany Nicole Tanaka, MD
08:45 AM - 08:55 AM
Case 2: R/R ALL in a young adult — CAR-T vs BiTE vs salvage chemo OR Relapsed/refractory B-ALL – Sequencing of novel immunotherapies – Tamer Othman, MD, MD
08:55 AM - 09:15 AM
Case-Based Discussion
Moderator:
Vinod Pullarkat, MD
Panelists:
Tamer Othman, MD, MD; Tiffany Nicole Tanaka, MD
Session Chair: Caitlin Costello, MD
09:15 AM - 09:30 AM
Emerging Therapies in Multiple Myeloma – Aaron S Rosenberg, MD
09:30 AM - 09:35 AM
Emerging Therapies in Multiple Myeloma (Q&A)
09:35 AM - 09:45 AM
Case 1 - NDMM - role of transplant? PERSEUS vs CEPHEUS – Lisa Lee, MD
09:45 AM - 09:55 AM
Case 2: Early Relapse: CART vs. Bispecific – Sarah S Lee, MD, MD
09:55 AM - 10:10 AM
Case-Based Discussion
Moderator:
Caitlin Costello, MD
Panelists:
Aaron S Rosenberg, MD; Lisa Lee ; Sarah S Lee, MD, MD
Session Chair: Kentson Lam, MD PhD
10:55 AM - 11:10 AM
Modern Management of MDS and MPNs – Ling Huang
11:10 AM - 11:15 AM
Modern Management of MDS and MPNs (Q&A)
11:15 AM - 11:25 AM
Case: MDS/MPNs - Case Presenter TBD – Kentson Lam, MD PhD
11:25 AM - 11:40 AM
Case-Based Discussion
Moderator:
Kentson Lam, MD PhD
Panelist:
Ling Huang
Session Chair: Reema Batra , MD
01:00 PM - 01:15 PM
Current Approaches to R/R Disease – Marin Xavier, MD
01:15 PM - 01:20 PM
Current Approaches to R/R Disease (Q&A)
01:20 PM - 01:30 PM
Case 1: Double-hit DLBCL – Is intensified chemo (DA-EPOCH-R) still standard? – Reema Batra , MD
01:30 PM - 01:40 PM
Case 2: Primary refractory DLBCL – CAR-T vs. Bispecifics – Autumn Jeong, MD
01:40 PM - 02:00 PM
Case-Based Discussion
Moderator:
Reema Batra , MD
Panelists:
Autumn Jeong, MD; Geoffrey Shouse, PhD, DO; Marin Xavier, MD
Session Chair: Bita Fakhri, MD, MPH
02:15 PM - 02:30 PM
How I Treat CLL: Practical Decision-Making – Michael Choi, MD
02:30 PM - 02:35 PM
How I Treat CLL: Practical Decision-Making (Q&A)
02:35 PM - 02:45 PM
Case: CLL – Catherine Coombs, MD
02:45 PM - 03:00 PM
Case-Based Discussion
Moderator:
Bita Fakhri, MD, MPH
Panelists:
Michael Choi, MD; Catherine Coombs, MD
Session Chair: Benjamin Heyman, MD
03:00 PM - 03:15 PM
Optimizing Treatment Strategies in Low-Grade Lymphomas – Paul Cheng, MD, PhD
03:15 PM - 03:20 PM
Optimizing Treatment Strategies in Low-Grade Lymphomas (Q&A)
03:20 PM - 03:30 PM
Case: Low-grade Lymphomas – Benjamin Heyman, MD
03:30 PM - 03:45 PM
Case-Based Discussion
Moderator:
Benjamin Heyman, MD
Panelist:
Paul Cheng, MD, PhD
